Atossa Therapeutics, Inc.
8 clinical trials · Sponsor
◉ Watch Atossa Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer (NCT05607004) | Atossa Therapeutics, Inc. | 2023-02-14 |
| Effect of Oral (Z)-Endoxifen in Premenopausal Women With Measurable Breast Density (NCT05068388) | Atossa Therapeutics, Inc. | 2021-12-21 |
| AT-301 Nasal Spray in Healthy Adults (NCT04519788) | Atossa Therapeutics, Inc. | 2020-08-07 |
| Topical Endoxifen in Women (NCT04616430) | Atossa Therapeutics, Inc. | 2018-04-09 |
Track Atossa Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.